Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)

ConclusionDespite limited intravesical treatment options in BCG failure patients, there are several promising therapies currently being developed and several with promising early results.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research